UMICORE (UMI.BR)

BE0974320526 - Common Stock

18.44  -0.32 (-1.71%)

Fundamental Rating

4

Taking everything into account, UMI scores 4 out of 10 in our fundamental rating. UMI was compared to 62 industry peers in the Chemicals industry. UMI has an average financial health and profitability rating. UMI is valued correctly, but it does not seem to be growing.



5

1. Profitability

1.1 Basic Checks

UMI had positive earnings in the past year.
In the past year UMI had a positive cash flow from operations.
Each year in the past 5 years UMI has been profitable.
UMI had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

UMI has a better Return On Assets (3.86%) than 63.93% of its industry peers.
With a decent Return On Equity value of 10.52%, UMI is doing good in the industry, outperforming 73.77% of the companies in the same industry.
With a decent Return On Invested Capital value of 7.37%, UMI is doing good in the industry, outperforming 73.77% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for UMI is above the industry average of 7.69%.
Industry RankSector Rank
ROA 3.86%
ROE 10.52%
ROIC 7.37%
ROA(3y)5.48%
ROA(5y)4.42%
ROE(3y)15.54%
ROE(5y)12.57%
ROIC(3y)10.16%
ROIC(5y)8.82%

1.3 Margins

UMI's Profit Margin of 2.11% is in line compared to the rest of the industry. UMI outperforms 47.54% of its industry peers.
In the last couple of years the Profit Margin of UMI has declined.
UMI has a Operating Margin of 3.23%. This is comparable to the rest of the industry: UMI outperforms 52.46% of its industry peers.
UMI's Operating Margin has been stable in the last couple of years.
UMI has a worse Gross Margin (8.24%) than 86.89% of its industry peers.
UMI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.23%
PM (TTM) 2.11%
GM 8.24%
OM growth 3Y19.34%
OM growth 5Y-0.8%
PM growth 3Y49.37%
PM growth 5Y-1.82%
GM growth 3Y13.74%
GM growth 5Y-1.13%

4

2. Health

2.1 Basic Checks

UMI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for UMI remains at a similar level compared to 1 year ago.
Compared to 5 years ago, UMI has less shares outstanding
Compared to 1 year ago, UMI has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 3.12 indicates that UMI is not in any danger for bankruptcy at the moment.
UMI has a Altman-Z score of 3.12. This is in the better half of the industry: UMI outperforms 72.13% of its industry peers.
The Debt to FCF ratio of UMI is 17.40, which is on the high side as it means it would take UMI, 17.40 years of fcf income to pay off all of its debts.
UMI has a Debt to FCF ratio (17.40) which is comparable to the rest of the industry.
UMI has a Debt/Equity ratio of 0.55. This is a neutral value indicating UMI is somewhat dependend on debt financing.
UMI has a Debt to Equity ratio (0.55) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 17.4
Altman-Z 3.12
ROIC/WACC1.26
WACC5.85%

2.3 Liquidity

UMI has a Current Ratio of 1.62. This is a normal value and indicates that UMI is financially healthy and should not expect problems in meeting its short term obligations.
UMI has a Current ratio of 1.62. This is in the lower half of the industry: UMI underperforms 67.21% of its industry peers.
UMI has a Quick Ratio of 1.62. This is a bad value and indicates that UMI is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.82, UMI is doing worse than 81.97% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 0.82

3

3. Growth

3.1 Past

UMI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.70%.
Measured over the past 5 years, UMI shows a small growth in Earnings Per Share. The EPS has been growing by 4.10% on average per year.
Looking at the last year, UMI shows a very negative growth in Revenue. The Revenue has decreased by -28.19% in the last year.
UMI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.90% yearly.
EPS 1Y (TTM)-24.7%
EPS 3Y11.55%
EPS 5Y4.1%
EPS Q2Q%-21.24%
Revenue 1Y (TTM)-28.19%
Revenue growth 3Y-4.1%
Revenue growth 5Y5.9%
Sales Q2Q%-85.58%

3.2 Future

UMI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.84% yearly.
The Revenue is expected to grow by 4.62% on average over the next years.
EPS Next Y-17.19%
EPS Next 2Y-7.61%
EPS Next 3Y-3.14%
EPS Next 5Y3.84%
Revenue Next Year-4.28%
Revenue Next 2Y1.78%
Revenue Next 3Y4.32%
Revenue Next 5Y4.62%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.91, the valuation of UMI can be described as very reasonable.
Based on the Price/Earnings ratio, UMI is valued cheaper than 96.72% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.24. UMI is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 11.97 indicates a reasonable valuation of UMI.
UMI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. UMI is cheaper than 75.41% of the companies in the same industry.
UMI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 19.93.
Industry RankSector Rank
PE 9.91
Fwd PE 11.97

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, UMI is valued a bit cheaper than the industry average as 77.05% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, UMI is valued a bit cheaper than 62.30% of the companies in the same industry.
Industry RankSector Rank
P/FCF 28.77
EV/EBITDA 6.58

4.3 Compensation for Growth

A cheap valuation may be justified as UMI's earnings are expected to decrease with -3.14% in the coming years.
PEG (NY)N/A
PEG (5Y)2.42
EPS Next 2Y-7.61%
EPS Next 3Y-3.14%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.80%, UMI has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.94, UMI pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, UMI has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.8%

5.2 History

The dividend of UMI has a limited annual growth rate of 1.00%.
Dividend Growth(5Y)1%
Div Incr Years0
Div Non Decr Years3

5.3 Sustainability

49.94% of the earnings are spent on dividend by UMI. This is a bit on the high side, but may be sustainable.
UMI's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP49.94%
EPS Next 2Y-7.61%
EPS Next 3Y-3.14%

UMICORE

EBR:UMI (5/24/2024, 7:00:00 PM)

18.44

-0.32 (-1.71%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.54B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 2.8%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 9.91
Fwd PE 11.97
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)2.42
Profitability
Industry RankSector Rank
ROA 3.86%
ROE 10.52%
ROCE
ROIC
ROICexc
ROICexgc
OM 3.23%
PM (TTM) 2.11%
GM 8.24%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.83
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.62
Quick Ratio 0.82
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-24.7%
EPS 3Y11.55%
EPS 5Y
EPS Q2Q%
EPS Next Y-17.19%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-28.19%
Revenue growth 3Y-4.1%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y